As drug and supplement companies increasingly turn to platforms like Twitter and Facebook to engage with patients and customers, it’s clear the FDA is actively monitoring what’s being said on these platforms just as they track communications on corporate websites.
In 2013, the supplement firm AMARC Enterprises made headlines when it was hit with a warning letter from the FDA for “liking” a post a customer left on the company’s Facebook page which praised the company’s supplement for warding off cancer without chemotherapy or radiation. To the FDA, the company’s “like” constituted an unauthorized drug claim.
With such a strong precedent set, companies are now wondering what it means for other social platforms like Twitter. Specifically, how do you ensure communications are compliant with regulatory standards in 140 characters or less?
To answer that question, we’ve broken down the three ingredients of a compliant tweet––a formula you can adapt to your own social media strategy. Before we get to that, however, let’s briefly look at the FDA’s guidance on social media use and how it applies to the microblogging site Twitter in particular.
Use the first 40 characters to sum up the benefits as concisely as possible. Given such little space, it may be best to focus on either one particular benefit or the overall benefit rather than try to list each one by one.
In the interest of saving space, highlight the most serious risk along with a link to a complete list of risk information. Be sure to shorten any links to save on space. Long hyperlinks can often take up the majority of a tweet.
The FDA requires communications like these to name the product by its official approved title. Keep this in mind when planning the content of your tweets. The longer your product name, the less space you have to build your message.
While it seems like technology is constantly outpacing the FDA’s ability to regulate, the Agency has shown it intends to address new methods of communication as pharmaceutical companies continue to expand their marketing efforts.
Today, there are a number of guidances, warning letter examples and other instances from which to understand the FDA’s position on online communications.
As platforms like Twitter continue to roll out new ways for companies to connect with customers socially, it’s clear these online spaces will only become more important in the broader media and advertising landscape.
Want to learn more about the FDA’s official guidance on social media use? Grab our free whitepaper: The Food and Drug Administration’s Policy On Social Media Use